Original document(6 pages)  中文版
    The indapamide slow-released tablet includes tablet core and coating, in which the tablet core is formed from indapamide, slow-releasing material, pore-forming agent, filling agent and lubricating agent in the ratio of 1.5g:40-150g:20-100g:10-100g:1-10g, and the coating is formed from film-forming amterial, antisticking agent, masking agent, polyethylene glycol 400, distrilled water and ethyl alcohol. The above-mentioned film-forming material, antisticking agent, masking agent, polyethylene glycol 400 and distilled water according to the ratio of 3-20g:2-15g:1-15g:5ml:140ml are added into the ethyl alcohol, and diluted with ethyl alcohol to 500ml to obtain the coating solution, then the outer layer of the tablet can be coated with said coating solution and dried so as to obtain the invented indapamide slow-release tablet.
Application Number
申请号
02123999 Application Date
申请日
2002.07.12
Title 名称 Indapamide slowly-releasing tablet
Publication Number
公开号
1394604 Publication Date
公开日
2003.02.05
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K9/22,A61K31/404,A61P7/10,A61P9/12
Applicant(s) Name
申请人
Yan Jie
Address 地址 300202
Inventor(s) Name 发明人
Attorney & Agent 代理人 pang huaxin
More information 更  多  信  息


 Related patents information
Process for preparing slow-releasing indapamide tablet
Complex acetaminophen vitamin C dispersion tablet and preparing method thereof
Andrographolide dispersing tablets
Sustained release formulation with cetirizine and pseudoephedrine hydronate
Methocarbamol dry mixing suspension
Herbeishatan hydrochlorothiazine dispersion tablet
Quisnon dispersion tablet
Methocarbamol dispersion tablet
Mitiglinide calcium formulation formula
Preparation of mitiglinide calcium and its quality control method
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.